SEC Form D · filed February 15, 2022
Armis Biopharma, Inc
Industry
Other Health Care
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Alan Smith, Ph.D · Fort Collins, CODirectorMichael Litwack · Fort Collins, CODirectorEd Neas, Ph.D · Fort Collins, CODirectorWilliam Nelson, Md. Ph.D · Fort Collins, CODirectorChristopher Ruud · Fort Collins, COExec · DirectorSteve Coder · Fort Collins, COExec · DirectorTed Ziemann · Fort Collins, COExec · DirectorAlan Ruud · Fort Collins, CADirectorKurt Gibson · Brandon, FLDirectorLauren Chung · New York, NYDirectorMatthew G. Coleman · FORT WORTH, TXExec · DirectorCS Starland Savannah 2023 Manager LLC · Morristown, NJDirectorChristopher Gibson · Brandon, FLExec · DirectorArmaan Ali · SAN FRANCISCO, CADirectorDeborah Ginsberg · NEW YORK, NYExec · DirectorSarah Baker · Portland, ORDirectorJulia O'Mara · New York, NYDirectorRick Heitzmann · New York, NYExec · DirectorBrian Mcmahon · New York, NYExec · DirectorQuinton C. Hennigh · Denver, COExec · DirectorOtavio C. Costa · Denver, CODirectorJeffery Sarrett · NEW YORK, NYDirectorAlan Ruud · Fort Collins, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗